LS Investment Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,868
| Closed | -$912K | – | 747 |
|
|
2021
Q1 | $912K | Sell |
5,868
-955
| -14% | -$148K | 0.05% | 245 |
|
|
2020
Q4 | $1.02M | Sell |
6,823
-250
| -4% | -$35.3K | 0.05% | 274 |
|
|
2020
Q3 | $935K | Buy |
7,073
+163
| +2% | +$21.3K | 0.05% | 266 |
|
|
2020
Q2 | $801K | Buy |
6,910
+931
| +16% | +$107K | 0.05% | 281 |
|
|
2020
Q1 | $587K | Sell |
5,979
-707
| -11% | -$92.7K | 0.04% | 296 |
|
|
2019
Q4 | $972K | Sell |
6,686
-934
| -12% | -$129K | 0.05% | 305 |
|
|
2019
Q3 | $1.02M | Buy |
7,620
+57
| +0.8% | +$7.36K | 0.06% | 278 |
|
|
2019
Q2 | $865K | Sell |
7,563
-46
| -0.6% | -$5.39K | 0.05% | 307 |
|
|
2019
Q1 | $943K | Buy |
7,609
+206
| +3% | +$23.4K | 0.06% | 285 |
|
|
2018
Q4 | $745K | Buy |
7,403
+332
| +5% | +$37.3K | 0.05% | 301 |
|
|
2018
Q3 | $903K | Sell |
7,071
-109
| -2% | -$13K | 0.05% | 311 |
|
|
2018
Q2 | $777K | Sell |
7,180
-217
| -3% | -$23.6K | 0.05% | 342 |
|
|
2018
Q1 | $783K | Sell |
7,397
-197
| -3% | -$22.9K | 0.05% | 345 |
|
|
2017
Q4 | $890K | Sell |
7,594
-24
| -0.3% | -$2.71K | 0.05% | 307 |
|
|
2017
Q3 | $866K | Buy |
7,618
+286
| +4% | +$33K | 0.05% | 305 |
|
|
2017
Q2 | $914K | Buy |
7,332
+154
| +2% | +$18.3K | 0.06% | 288 |
|
|
2017
Q1 | $851K | Buy |
7,178
+820
| +13% | +$92.9K | 0.05% | 283 |
|
|
2016
Q4 | $637K | Sell |
6,358
-7,319
| -54% | -$784K | 0.04% | 336 |
|
|
2016
Q3 | $1.73M | Sell |
13,677
-1,312
| -9% | -$162K | 0.13% | 157 |
|
|
2016
Q2 | $1.75M | Buy |
14,989
+8,233
| +122% | +$932K | 0.12% | 171 |
|
|
2016
Q1 | $699K | Buy |
6,756
+203
| +3% | +$19.6K | 0.05% | 293 |
|
|
2015
Q4 | $653K | Buy |
6,553
+112
| +2% | +$11K | 0.05% | 301 |
|
|
2015
Q3 | $587K | Buy |
6,441
+493
| +8% | +$49.4K | 0.05% | 311 |
|
|
2015
Q2 | $631K | Sell |
5,948
-165
| -3% | -$18.3K | 0.05% | 294 |
|
|
2015
Q1 | $697K | Sell |
6,113
-12
| -0.2% | -$1.37K | 0.05% | 278 |
|
|
2014
Q4 | $675K | Sell |
6,125
-521
| -8% | -$54.9K | 0.05% | 262 |
|
|
2014
Q3 | $649K | Sell |
6,646
-54
| -0.8% | -$5.31K | 0.06% | 252 |
|
|
2014
Q2 | $676K | Sell |
6,700
-10,355
| -61% | -$1.01M | 0.06% | 240 |
|
|
2014
Q1 | $1.57M | Buy |
17,055
+2,116
| +14% | +$195K | 0.13% | 161 |
|
|
2013
Q4 | $1.35M | Buy |
14,939
+13,520
| +953% | +$1.17M | 0.12% | 161 |
|
|
2013
Q3 | $113K | Buy |
1,419
+416
| +41% | +$32.7K | 0.01% | 280 |
|
|
2013
Q2 | $73K | Buy |
+1,003
| New | +$75K | 0.01% | 283 |
|
Other funds holding ZBH
N
LS Investment Advisors's ZBH Position: Q2 2021 in Review
LS Investment Advisors sold out of Zimmer Biomet (ZBH) in Q2 2021, closing a stake of 5,868 shares — an estimated $912K sold.
LS Investment Advisors first reported a position in ZBH in Q2 2013 and held it in 32 quarters. The position peaked at $1.75M in Q2 2016. 1,018 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.
- LS Investment Advisors reported no remaining Zimmer Biomet position as of Q2 2021 after selling out during the quarter.
- LS Investment Advisors sold 5,868 Zimmer Biomet shares in Q2 2021, an estimated $912K.
- LS Investment Advisors first reported a position in Zimmer Biomet in Q2 2013 and held it in 32 quarters.
- LS Investment Advisors's Zimmer Biomet position peaked at $1.75M in Q2 2016.
- 1,018 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.
Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.